The authors designed a combination of haplo‐hematopoietic stem cells transplantation with allogenic mesenchymal stem cells for treatment of severe aplastic anemia in pediatric and adolescent patients and evaluated its effects.
[Stem Cells Translational Medicine]
1254621 {1254621:TBRG8NDP} apa 50 1 154591 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-251ef61bccfd16bee8ffa81fdd8b0a17%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22TBRG8NDP%22%2C%22library%22%3A%7B%22id%22%3A1254621%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ding%20et%20al.%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDing%2C%20L.%2C%20Han%2C%20D.-M.%2C%20Zheng%2C%20X.-L.%2C%20Yan%2C%20H.-M.%2C%20Xue%2C%20M.%2C%20Liu%2C%20J.%2C%20Zhu%2C%20L.%2C%20Li%2C%20S.%2C%20Mao%2C%20N.%2C%20Guo%2C%20Z.-K.%2C%20Ning%2C%20H.-M.%2C%20Wang%2C%20H.-X.%2C%20%26amp%3B%20Zhu%2C%20H.%20%28n.d.%29.%20A%20study%20of%20human%20leukocyte%20antigen-haploidentical%20hematopoietic%20stem%20cells%20transplantation%20combined%20with%20allogenic%20mesenchymal%20stem%20cell%20infusion%20for%20treatment%20of%20severe%20aplastic%20anemia%20in%20pediatric%20and%20adolescent%20patients.%20%3Ci%3ESTEM%20CELLS%20Translational%20Medicine%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fsctm.20-0345%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fsctm.20-0345%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1254621%26amp%3Bitem_key%3DTBRG8NDP%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20study%20of%20human%20leukocyte%20antigen-haploidentical%20hematopoietic%20stem%20cells%20transplantation%20combined%20with%20allogenic%20mesenchymal%20stem%20cell%20infusion%20for%20treatment%20of%20severe%20aplastic%20anemia%20in%20pediatric%20and%20adolescent%20patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Ding%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dong-Mei%22%2C%22lastName%22%3A%22Han%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao-Li%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hong-Min%22%2C%22lastName%22%3A%22Yan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei%22%2C%22lastName%22%3A%22Xue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ling%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheng%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ning%22%2C%22lastName%22%3A%22Mao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zi-Kuan%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hong-Mei%22%2C%22lastName%22%3A%22Ning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heng-Xiang%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heng%22%2C%22lastName%22%3A%22Zhu%22%7D%5D%2C%22abstractNote%22%3A%22The%20clinical%20applications%20of%20human%20leukocyte%20antigen%20%28HLA%29%20haploidentical%20hematopoietic%20stem%20cells%20transplantation%20%28haplo-HSCT%29%20have%20offered%20most%20of%20the%20young%20severe%20aplastic%20anemia%20%28SAA%29%20patients%20an%20opportunity%20to%20accept%20curative%20therapy%20at%20the%20early%20stage%20of%20bone%20marrow%20lesions.%20However%2C%20the%20outcome%20of%20juvenile%20SAA%20patients%20received%20haplo-HSCT%20remain%20to%20be%20improved%20due%20to%20high%20incidence%20of%20graft%20failure%20and%20graft%20vs%20host%20disease%20%28GVHD%29.%20Mesenchymal%20stem%20cells%20%28MSCs%29%20have%20been%20characterized%20by%20their%20hematopoiesis-supporting%20and%20immunomodulatory%20properties.%20In%20the%20current%20study%2C%20we%20designed%20a%20combination%20of%20haplo-HSCT%20with%20allogenic%20MSC%20for%20treatment%20of%20SAA%20in%20pediatric%20and%20adolescent%20patients%20and%20evaluated%20its%20effects.%20Juvenile%20patients%20%28%3C18%20years%29%20with%20SAA%20%28n%20%3D%20103%29%20were%20given%20HLA-haploidentical%20HSC%20combined%20with%20allogenic%20MSC%20after%20a%20conditioning%20regimen%20consisting%20of%20busulfan%2C%20cyclophosphamide%2C%20fludarabine%2C%20and%20antithymocyte%20globulin%20and%20an%20intensive%20GVHD%20prophylaxis%2C%20including%20cyclosporine%2C%20short-term%20methotrexate%2C%20mycophenolate%20mofetil%2C%20and%20basiliximab.%20Neutrophil%20engraftment%20was%20achieved%20in%20102%20of%20103%20patients%20in%20a%20median%20time%20of%2014.3%20days%20%28range%209-25%20days%29.%20The%20median%20time%20of%20platelet%20engraftment%20was%2025.42%20days%20%28range%208-93%20days%29.%20The%20cumulative%20incidence%20of%20II-IV%20acute%20GVHD%20at%20day%20%2B100%20was%2026.32%25%20%5Cu00b1%200.19%25%20and%20III-IV%20acute%20GVHD%20was%206.79%25%20%5Cu00b1%200.06%25%20at%20day%20%2B100%2C%20respectively.%20The%20cumulative%20incidence%20of%20chronic%20GVHD%20was%2025.56%25%20%5Cu00b1%200.26%25.%20The%20overall%20survival%20was%2087.15%25%20%5Cu00b1%203.3%25%20at%20a%20median%20follow-up%20of%2040%20%281.3-98%29%20months.%20Our%20data%20suggest%20that%20cotransplantation%20of%20HLA-haploidentical%20HSC%20and%20allogenic%20mesenchymal%20stem%20cell%20may%20provide%20an%20effective%20and%20safe%20treatment%20for%20children%20and%20adolescents%20with%20SAA%20who%20lack%20matched%20donors.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2Fsctm.20-0345%22%2C%22ISSN%22%3A%222157-6580%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fstemcellsjournals.onlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fsctm.20-0345%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-09-28T19%3A03%3A49Z%22%7D%7D%5D%7D
Ding, L., Han, D.-M., Zheng, X.-L., Yan, H.-M., Xue, M., Liu, J., Zhu, L., Li, S., Mao, N., Guo, Z.-K., Ning, H.-M., Wang, H.-X., & Zhu, H. (n.d.). A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients. STEM CELLS Translational Medicine, n/a(n/a). https://doi.org/10.1002/sctm.20-0345 Cite